| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d97cb748898aa080b013f7f35bc8b434 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2103-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2303-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2303-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2303-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2303-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2303-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F2103-023 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C02F1-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-76 |
| filingDate |
2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30f2c3064b6aa87b3c6b912e6f90cc29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82bef4c8ebc287b9734dc5fdfe9a2833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8594d16e33588b021d2357cc51410d1e |
| publicationDate |
2019-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I677485-B |
| titleOfInvention |
Method for inhibiting reduction of isothiazoline compound concentration |
| abstract |
Provided is a method for suppressing a decrease in the concentration of an isothiazoline compound in an aqueous system, which suppresses the decrease in the concentration even if the isothiazoline compound used as an antibacterial agent has a low added concentration, and achieves an increase in the residual rate after 24 hours. A method for suppressing a decrease in the concentration of an isothiazoline compound, in which an isothiazoline compound is supplied in an aqueous system at an addition concentration of 0.2 mg / L or more and less than 1 mg / L, and is maintained at 0.3 in terms of Cl 2 conversion. A combined chlorine agent containing a chlorine stabilizer and a chlorine-based oxidant is added in a range of mg / L or more and 6 mg / L or less. |
| priorityDate |
2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |